Andrew Lewis
Chief Executive Officer presso New Zealand Pharmaceuticals Ltd.
Profilo
Andrew Lewis is currently the Chief Executive Officer & Director at New Zealand Pharmaceuticals Ltd.
since 2010.
He is also a Member at the Institute of Directors in New Zealand, Inc. Mr. Lewis was formerly the Chief Executive Officer at Dextra Laboratories Ltd.
Mr. Lewis holds an MBA degree from Massey University.
Posizioni attive di Andrew Lewis
| Società | Posizione | Inizio |
|---|---|---|
New Zealand Pharmaceuticals Ltd.
 New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology New Zealand Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies. Its products include pharmaceutical intermediates and ingredients, excipients, carbohydrates, dietary supplements, and feed ingredients. The company was founded in 1971 and is headquartered in Palmerston North, New Zealand. | Chief Executive Officer | 01/03/2010 |
Institute of Directors in New Zealand, Inc.
 Institute of Directors in New Zealand, Inc. Miscellaneous Commercial ServicesCommercial Services Institute of Directors in New Zealand, Inc. operates as a membership organization. The company is headquartered in Wellington, New Zealand. | Corporate Officer/Principal | - |
Precedenti posizioni note di Andrew Lewis
| Società | Posizione | Fine |
|---|---|---|
Dextra Laboratories Ltd.
 Dextra Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICE SpA, Dextra Laboratories Ltd. researches and develops biomedical carbohydrate products and provides ancillary services to pharmaceutical and biotechnology companies. The private company is based in Reading, UK. Dextra Laboratories was acquired by New Zealand Pharmaceuticals Ltd., a SUB of ICE SpA from Summit Therapeutics Ltd. on September 02, 2009 for $1.54 million. | President | - |
Formazione di Andrew Lewis
| Massey University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
New Zealand Pharmaceuticals Ltd.
New Zealand Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology New Zealand Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies. Its products include pharmaceutical intermediates and ingredients, excipients, carbohydrates, dietary supplements, and feed ingredients. The company was founded in 1971 and is headquartered in Palmerston North, New Zealand. | Health Technology |
Dextra Laboratories Ltd.
Dextra Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICE SpA, Dextra Laboratories Ltd. researches and develops biomedical carbohydrate products and provides ancillary services to pharmaceutical and biotechnology companies. The private company is based in Reading, UK. Dextra Laboratories was acquired by New Zealand Pharmaceuticals Ltd., a SUB of ICE SpA from Summit Therapeutics Ltd. on September 02, 2009 for $1.54 million. | Commercial Services |
Institute of Directors in New Zealand, Inc.
Institute of Directors in New Zealand, Inc. Miscellaneous Commercial ServicesCommercial Services Institute of Directors in New Zealand, Inc. operates as a membership organization. The company is headquartered in Wellington, New Zealand. | Commercial Services |
- Borsa valori
- Insiders
- Andrew Lewis
